Overview

Efficacy and Safety of PL9643 Ophthalmic Solution in Subjects With Dry Eye

Status:
Completed
Trial end date:
2020-10-05
Target enrollment:
Participant gender:
Summary
Evaluation of safety and efficacy of PL9643 Ophthalmic Solution compared to placebo for the treatment of the signs and symptoms of dry eye.
Phase:
Phase 2
Details
Lead Sponsor:
ORA, Inc.
Collaborator:
Palatin Technologies
Treatments:
Ophthalmic Solutions
Pharmaceutical Solutions